A novel poly(l -glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions

Molecular Pharmaceutics

Volumn 7, Issue 4, 2010, Pages 953-962

  Yuan, Hui ^a   Luo, Kui ^a   Lai, Yusi ^a   Pu, Yuji ^a   He, Bin ^a   Wang, Gang ^a   Wu, Yao ^a   Gu, Zhongwei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

doxorubicin; drug delivery; pH sensitive; Poly(L glutamic acid) dendrimer; targeting

Indexed keywords

BIOTIN; DENDRIMER; DOXORUBICIN; DRUG VEHICLE; HYDRAZINE; POLYGLUTAMIC ACID; POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; PH MEASUREMENT; PRIORITY JOURNAL;

DENDRIMERS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, THEORETICAL; NANOPARTICLES; ORGANOSILICON COMPOUNDS; POLYGLUTAMIC ACID;

EID: 77955247993     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp1000923     Document Type: Article

References (39)

1. Vandamme, T. F.; Brobeck, L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide J. Controlled Release 2005, 102 (1) 23-38
2. Bai, S.; Thomas, C.; Ahsan, F. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin J. Pharm. Sci. 2007, 96 (8) 2090-2106
3. Yiyun, C.; Na, M.; Tongwen, X.; Rongqiang, F.; Xueyuan, W.; Xiaomin, W.; Longping, W. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers J. Pharm. Sci. 2007, 96 (3) 595-602
4. Najlah, M.; Freeman, S.; Attwood, D.; D'Emanuele, A. In vitro evaluation of dendrimer prodrugs for oral drug delivery Int. J. Pharm. 2007, 336 (1) 183-190
5. Crespo, L.; Sanclimens, G.; Pons, M.; Giralt, E.; Royo, M.; Albericio, F. Peptide and amide bond-containing dendrimers Chem. Rev. 2005, 105 (5) 1663-1681
6. Najlah, M.; Freeman, S.; Attwood, D.; D'Emanuele, A. Synthesis, characterization and stability of dendrimer prodrugs Int. J. Pharm. 2006, 308 (1-'2) 175-182
7. McCusker, C.; Carroll, J. B.; Rotello, V. M. Cationic polyhedral oligomeric silsesquioxane (POSS) units as carriers for drug delivery processes Chem. Commun. 2005, 8) 996-998
8. Kaneshiro, T. L.; Wang, X.; Lu, Z. R. Synthesis, characterization, and gene delivery of Poly-L-lySine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular Architectures Mol. Pharmaceutics 2007, 4 (5) 759-768
9. 12 frameworks: a revolutionary new method for manufacturing precursors to hybrid inorganic-'organic materials Chem. Commun. 1998, 399-400 (Pubitemid 128675273)
10. Tomalia, D. A.; Naylor, A. M.; Goddard, W. A., III. Starburst Dendrimers: Molecular-Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter Angew. Chem., Int. Ed. Engl. 1990, 29 (2) 138-175
11. Kaneshiro, T. L.; Lu, Z. R. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier Biomaterials 2009, 30 (29) 5660-5666
12. Tanaka, T.; Shiramoto, S.; Miyashita, M.; Fujishima, Y.; Kaneo, Y. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME) Int. J. Pharm. 2004, 277 (1-'2) 39-61
13. Dobson, P. D.; Kell, D. B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule Nat. Rev. Drug Discovery 2008, 7 (3) 205-220
14. Kannan, R. Y.; Salacinski, H. J.; Butler, P. E.; Seifalian, A. M. Polyhedral oligomeric silsesquioxane nanocomposites: The next generation material for biomedical applications Acc. Chem. Res. 2005, 38 (11) 879-884
15. Bhadra, D.; Yadav, A. K.; Bhadra, S.; Jain, N. K. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting Int. J. Pharm. 2005, 295 (1-'2) 221-233
16. Majoros, I. J.; Myc, A.; Thomas, T.; Mehta, C. B.; Baker, J. R. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality Biomacromolecules 2006, 7 (2) 572-579
17. Shukla, R.; Thomas, T. P.; Peters, J. L.; Desai, A. M.; Kukowska-Latallo, J.; Patri, A. K.; Kotlyar, A.; Baker, J. R. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb Bioconjugate Chem. 2006, 17 (5) 1109-1115
18. Shukla, R.; Thomas, T. P.; Peters, J.; Kotlyar, A.; Myc, A.; Baker, J. R. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates Chem. Commun. 2005, 46) 5739-5741
19. Yang, W. L.; Barth, R. F.; Wu, G.; Bandyopadhyaya, A. K.; Thirumamagal, B. T. S.; Tjarks, W.; Binns, P. J.; Riley, K.; Patel, H.; Coderre, J. A.; Ciesielski, M. J.; Fenstermaker, R. A. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas Appl. Radiat. Isot. 2004, 61 (5) 981-985 (Pubitemid 39092651)
20. Yellepeddi, V. K.; Kumar, A.; Palakurthi, S. Biotinylated Poly(amido)amine (PAMAM) Dendrimers as Carriers for Drug Delivery to Ovarian Cancer Cells In Vitro Anticancer Res. 2009, 29 (8) 2933-2943
21. Minko, T.; Paranjpe, P. V.; Qiu, B.; Lalloo, A.; Won, R.; Stein, S.; Sinko, P. J. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethyleneglycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells Cancer Chemother. Pharmacol. 2002, 50 (2) 143-150
22. Russell-Jones, G.; McTavish, K.; McEwan, J.; Rice, J.; Nowotnik, D. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours J. Inorg. Biochem. 2004, 98 (10) 1625-1633
23. Gravel, M. C.; Zhang, C.; Dinderman, M.; Laine, R. M. Octa(3-chloroammoniumpropyl) octasilsesquioxane Appl. Organomet. Chem. 1999, 13 (4) 329-336
24. Tanaka, K.; Inafuku, K.; Adachi, S.; Chujo, Y. Tuning of properties of POSS-condensed water-soluble network polymers by modulating the cross-linking ratio between POSS Macromolecules 2009, 42 (10) 3489-3492
25. Bredihhin, A.; Maeorg, U. Effective strategy for the systematic synthesis of hydrazine derivatives Tetrahedron 2008, 64 (28) 6788-6793
26. Feher, F. J.; Wyndham, K. D.; Soulivong, D.; Nguyen, F. Syntheses of highly functionalized cube-octameric polyhedral oligosilsesquioxanes (R8Si8O12) J. Chem. Soc., Dalton Trans. 1999, 9) 1491-1497
27. Naka, K.; Fujita, M.; Tanaka, K.; Chujo, Y. Water-soluble anionic POSS-Core dendrimer: Synthesis and copper(II) complexes in aqueous solution Langmuir 2007, 23 (17) 9057-9063
28. Kono, K.; Kojima, C.; Hayashi, N.; Nishisaka, E.; Kiura, K.; Wataral, S.; Harada, A. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin Biomaterials 2008, 29 (11) 1664-1675
29. Kono, K.; Liu, M. J.; Frechet, J. M. J. Design of dendritic macromolecules containing folate or methotrexate residues Bioconjugate Chem. 1999, 10 (6) 1115-1121
30. Yang, W. J.; Cheng, Y. Y.; Xu, T. W.; Wang, X. Y.; Wen, L. P. Targeting cancer cells with biotin-dendrimer conjugates Eur. J. Med. Chem. 2009, 44 (2) 862-868
31. Marek, M.; Kaiser, K.; Gruber, H. J. Biotin-pyrene conjugates with poly(ethylene glycol) spacers are convenient fluorescent probes for avidin and streptavidin Bioconjugate Chem. 1997, 8 (4) 560-566
32. Cannizzaro, S. M.; Padera, R. F.; Langer, R.; Rogers, R. A.; Black, F. E.; Davies, M. C.; Tendler, S. J. B.; Shakesheff, K. M. A novel biotinylated degradable polymer for cell-interactive applications Biotechnol. Bioeng. 1998, 58 (5) 529-535
33. Na, K.; Lee, T. B.; Park, K. H.; Shin, E. K.; Lee, Y. B.; Cho, H. K. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system Eur. J. Pharm. Sci. 2003, 18 (2) 165-173
34. Â) J. Controlled Release 2002, 80 (1-'3) 129-144
35. Savic, R.; Luo, L.; Eisenberg, A.; Maysinger, D. Micellar nanocontainers distribute to defined cytoplasmic organelles Science 2003, 300 (5619) 615-618
36. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 1995, 55 (17) 3752-3756
37. 125I-labelled polyamidoamine dendrimers in vivo [Journal of Controlled Release 65 (2000) 133-'148] J. Controlled Release 2000, 68 (2) 299-302
38. Gillies, E. R.; Frechet, J. M. J. pH-responsive copolymer assemblies for controlled release of doxorubicin Bioconjugate Chem. 2005, 16 (2) 361-368
39. Ulbrich, K.; Subr, V. Polymeric anticancer drugs with pH-controlled activation Adv. Drug Delivery Rev. 2004, 56 (7) 1023-1050 (Pubitemid 38520207)